Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F13%3A00071001" target="_blank" >RIV/00216224:14110/13:00071001 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/65269705:_____/13:#0002045 RIV/00159816:_____/13:00060561
Výsledek na webu
<a href="http://dx.doi.org/10.5507/bp.2012.101" target="_blank" >http://dx.doi.org/10.5507/bp.2012.101</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2012.101" target="_blank" >10.5507/bp.2012.101</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients
Popis výsledku v původním jazyce
Background. Plasma N-terminal fragment of pro brain natriuretic peptide (NT-proBNP) concentration is elevated in cardiovascular diseases such as congestive heart failure, where increased levels of NT-proBNP indicate cardiac dysfunction, hypervolemia, andhigher risk of hospitalization and death. These associations apply also to patients with severe impairment of kidney function. Little is known about diferences in plasma level of NT-proBNP in patients receiving hemodialysis (HD) versus those receiving continuous ambulatory peritoneal dialysis (CAPD). Aim. To evaluate differences in plasma NT-proBNP concentration between HD and CAPD patients. Methods. Plasma NT-proBNP concentration was prospectively measured in consecutive patients receiving either HD or CAPD at our hospital center. All other standard clinical parameters were recorded. The correlation between plasma NT-proBNP concentration and the type of dialysis was then examined. Results.
Název v anglickém jazyce
Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients
Popis výsledku anglicky
Background. Plasma N-terminal fragment of pro brain natriuretic peptide (NT-proBNP) concentration is elevated in cardiovascular diseases such as congestive heart failure, where increased levels of NT-proBNP indicate cardiac dysfunction, hypervolemia, andhigher risk of hospitalization and death. These associations apply also to patients with severe impairment of kidney function. Little is known about diferences in plasma level of NT-proBNP in patients receiving hemodialysis (HD) versus those receiving continuous ambulatory peritoneal dialysis (CAPD). Aim. To evaluate differences in plasma NT-proBNP concentration between HD and CAPD patients. Methods. Plasma NT-proBNP concentration was prospectively measured in consecutive patients receiving either HD or CAPD at our hospital center. All other standard clinical parameters were recorded. The correlation between plasma NT-proBNP concentration and the type of dialysis was then examined. Results.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic
ISSN
1213-8118
e-ISSN
—
Svazek periodika
157
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
6
Strana od-do
325-330
Kód UT WoS článku
000329091500010
EID výsledku v databázi Scopus
—